skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: Recercat remove Database: Taylor & Francis Open Access remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Is iron deficiency modulating physical activity in COPD?
Material Type:
Article
Add to My Research

Is iron deficiency modulating physical activity in COPD?

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.211-214 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess Copyright © 2019 Martín-Ontiyuelo et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. http://creativecommons.org/licenses/by-nc/3.0/ ;2019 Martín-Ontiyuelo et al. This work is published and licensed by Dove Medical Press Limited 2019 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S182700 ;PMID: 30666101

Full text available

2
Impact of the sustained control of cardiovascular risk factors on first episode heart failure: The relevant role of primary care
Material Type:
Article
Add to My Research

Impact of the sustained control of cardiovascular risk factors on first episode heart failure: The relevant role of primary care

The European journal of general practice, 2015-10, Vol.21 (4), p.224-230 [Peer Reviewed Journal]

2015 Informa Healthcare 2015 ;cc-by (c) Muñoz, Miguel Ángel et al., 2015 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es ;ISSN: 1381-4788 ;EISSN: 1751-1402 ;DOI: 10.3109/13814788.2015.1049154 ;PMID: 26205157

Digital Resources/Online E-Resources

3
Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
Material Type:
Article
Add to My Research

Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

International journal of general medicine, 2017-01, Vol.10, p.23-26 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;cc-by-nc (c) Ampudia-Blasco, Francisco Javier, 2017 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc/3.0/es/ ;2017 Ampudia-Blasco et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-7074 ;EISSN: 1178-7074 ;DOI: 10.2147/IJGM.S115566 ;PMID: 28144158

Full text available

Searching Remote Databases, Please Wait